Evidence map›Paper›PMID 23351115›Full record

ArticleBritish journal of pharmacology2013

Detailed analysis of biased histamine H₄ receptor signalling by JNJ 7777120 analogues.

S Nijmeijer, H F Vischer, F Sirci, S Schultes, H Engelhardt, C de Graaf, E M Rosethorne, S J Charlton, R Leurs

Abstract readComparative Study
In one paragraph

Article in British journal of pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Trisubstituted 1,3,5-Triazines as Histamine HMolecules (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Review
  7. Review
  8. Aryl-1,3,5-triazine ligands of histamine HInflammation research : official journal of the European Histamine Research Society ... [et al.] · 2017
    Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Histamine H₄ receptors in the gastrointestinal tract.British journal of pharmacology · 2015
    Review
  15. Article
  16. Review
  17. Histamine pharmacology: four years on.British journal of pharmacology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

S NijmeijerFaculty of Sciences, Amsterdam Institute for Molecules, Medicines and Systems, VU University Amsterdam, The Netherlands.
H F Vischer
F Sirci
S Schultes
H Engelhardt
C de Graaf
E M Rosethorne
S J Charlton
R Leurs

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe histamine H₄ receptor, originally thought to signal merely through Gαi proteins, has recently been shown to also recruit and signal via β-arrestin2. Following the discovery that the reference antagonist indolecarboxamide JNJ 7777120 appears to be a partial agonist in β-arrestin2 recruitment, we have identified additional biased hH₄R ligands that preferentially couple to Gαi or β-arrestin2 proteins. In this study, we explored ligand and receptor regions that are important for biased hH₄R signalling. EXPERIMENTAL APPROACH: We evaluated a series of 48 indolecarboxamides with subtle structural differences for their ability to induce hH₄R-mediated Gαi protein signalling or β-arrestin2 recruitment. Subsequently, a Fingerprints for Ligands and Proteins three-dimensional quantitative structure-activity relationship analysis correlated intrinsic activity values with structural ligand requirements. Moreover, a hH₄R homology model was used to identify receptor regions important for biased hH₄R signalling. KEY

resultsOne indolecarboxamide (75) with a nitro substituent on position R7 of the aromatic ring displayed an equal preference for the Gαi and β-arrestin2 pathway and was classified as unbiased hH₄R ligand. The other 47 indolecarboxamides were β-arrestin2-biased agonists. Intrinsic activities of the unbiased as well as β-arrestin2-biased indolecarboxamides to induce β-arrestin2 recruitment could be correlated with different ligand features and hH₄R regions. CONCLUSION AND IMPLICATIONS: Small structural modifications resulted in diverse intrinsic activities for unbiased (75) and β-arrestin2-biased indolecarboxamides. Analysis of ligand and receptor features revealed efficacy hotspots responsible for biased-β-arrestin2 recruitment. This knowledge is useful for the design of hH₄R ligands with biased intrinsic activities and aids our understanding of the mechanism of H₄R activation.

Indexed as

Arrestinsbeta-ArrestinsCell Line, TumorDrug DesignGTP-Binding Protein alpha Subunits, Gi-GoHEK293 CellsHistamine AntagonistsHumansIndolesLigandsModels, MolecularPiperazinesQuantitative Structure-Activity RelationshipReceptors, G-Protein-CoupledReceptors, HistamineReceptors, Histamine H41-((5-chloro-1H-indol-2-yl)carbonyl)-4-methylpiperazineArrestinsbeta-ArrestinsGTP-Binding Protein alpha Subunits, Gi-GoHistamine AntagonistsHRH4 protein, humanIndolesLigandsPiperazinesReceptors, G-Protein-CoupledReceptors, HistamineReceptors, Histamine H4biased ligandsefficacyefficacy hotspotsFLAP 3D-QSARhistamine H4 receptorindolecarboxamidesintrinsic activityβ-arrestin

Identifiers

PMID23351115
PMCPMC3764851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.